CELLPROTHERA
CellProthera is the first company having conducted successful proof of principle study with autologous CD34+ stem cells to repair myocardial tissue after acute myocardial infarct (AMI). The clinical outcome indicated an excellent safety profile associated with outstanding clinical benefits. The innovative approach developed by CellProthera is viewed by experts as one of the most effective to treat AMI and prevent secondary congestive heart failure (CHF).
CELLPROTHERA
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Mulhouse, Alsace, France
Country:
France
Website Url:
http://www.cellprothera.com
Total Employee:
11+
Status:
Active
Contact:
+33369719771
Total Funding:
8.4 M EUR
Technology used in webpage:
Euro IPv6 3 To 9 CcTLD Redirects
Current Employees Featured
Founder
Investors List
Alsace Business Angels
Alsace Business Angels investment in Seed Round - CellProthera
Official Site Inspections
http://www.cellprothera.com Semrush global rank: 7.49 M Semrush visits lastest month: 472
- Host name: cluster007.ovh.net
- IP address: 213.186.33.18
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
